Rafferty Asset Management
BNTX icon

Rafferty Asset Management’s BioNTech BNTX Stock Holding History

Rafferty Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,296
Closed -$345K – 1146
2022
Q4 		$345K Buy
2,296
+472
+26% +$72.6K ﹤0.01% 982
2022
Q3 		$246K Sell
1,824
-238
-12% -$36.4K ﹤0.01% 1052
2022
Q2 		$307K Buy
2,062
+231
+13% +$35.3K ﹤0.01% 916
2022
Q1 		$312K Buy
1,831
+669
+58% +$112K ﹤0.01% 1094
2021
Q4 		$300K Buy
+1,162
New +$318K ﹤0.01% 1152

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Rafferty Asset Management's BNTX Position: Q1 2023 in Review

Rafferty Asset Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 2,296 shares — an estimated $345K sold.

Rafferty Asset Management first reported a position in BNTX in Q4 2021 and held it in 5 quarters. The position peaked at $345K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Rafferty Asset Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 2,296 BioNTech shares in Q1 2023, an estimated $345K.
  • Rafferty Asset Management first reported a position in BioNTech in Q4 2021 and held it in 5 quarters.
  • Rafferty Asset Management's BioNTech position peaked at $345K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.